Clinical trial Recruiting at 1 site Observational Ages 18 and up

Physical activity patterns in cancer survivors treated at the MOvement & REhabilitation clinic

Official title: Prospective Study on Physical Activity Trends in Cancer Survivors Treated at the 'MOvement and REhabilitation' (MO.RE) Clinic

Run by Azienda USL Reggio Emilia - IRCCS · NCT07373626 · Data updated 2026-11-12

This project will follow adult cancer survivors attending the MOvement & REhabilitation clinic to see how their weekly physical activity levels change over time after personalized physiotherapy support.

More Sedentary Behavior trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment50 (estimated)
SponsorAzienda USL Reggio Emilia - IRCCS
Government
Locations1 site (Reggio Emilia)
StatusRecruiting
StartedSeptember 1, 2025
Main results expectedFebruary 28, 2027
Study endsFebruary 28, 2027
Registry record updatedJanuary 28, 2026
Trial IDNCT07373626 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with a cancer diagnosis who can give informed consent, are able to participate in an independent physical activity program, and are referred to or attend the MOvement & REhabilitation clinic are ideal candidates.

Probably not a fit

Patients who require individualized rehabilitative treatment after physiatric assessment, those with significant cognitive or psychiatric impairments, or those with major language barriers are unlikely to benefit from this program.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The project enrolls adults with a cancer diagnosis who attend the MOvement & REhabilitation clinic and can participate in an independent exercise program. A dedicated physiotherapist provides personalized consultations and educational support, and the team records patients' weekly aerobic activity, clinical status, and barriers at baseline and during follow-up visits. The study tracks trends in meeting WHO-recommended activity levels (≥150 minutes moderate or ≥75 minutes vigorous per week) and documents reasons for changes in activity over time. Results aim to inform how clinic-based personalization influences long-term adoption of active lifestyles among cancer survivors.

Why it matters

Potential benefit: If successful, the findings could help clinics tailor support to increase patients' physical activity, reduce treatment-related side effects, and improve quality of life.

How similar studies have gone: Randomized trials and large meta-analyses have shown that physical activity reduces cancer-related fatigue and improves quality of life and survival, though single-center longitudinal tracking of activity after clinic-based personalization is less extensively characterized.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Diagnosis of cancer
* Age over 18 years
* Signed informed consent
* Patients for whom a physical exercise program can be proposed

Exclusion Criteria:

* Patients for whom the physiatric assessment identifies a need for individual rehabilitative treatment
* Significant language barrier
* Neuropsychological, psychiatric, or cognitive deficits, or clinical conditions that prevent participation in an independent physical activity program

Where it's running

  • Azienda USL IRCCS di Reggio Emilia - Unit of Physical Medicine and Rehabilitation
    Reggio Emilia, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.